A Novel CDK4/6 and PARP Dual Inhibitor ZC-22 Effectively Suppresses Tumor Growth and Improves the Response to Cisplatin Treatment in Breast and Ovarian Cancer

Chenchen Tian(Nankai University), Shuang Yang(Nankai University)
International Journal of Molecular Sciences
March 7, 2022
Cited by 16


Related Papers